List view / Grid view
AstraZeneca will begin testing whether they can improve the efficacy…
AstraZeneca will begin testing whether they can improve the efficacy of AZD1222 by combining it with the Ad26 human adenoviral vector from Russia’s Sputnik V vaccine.
The Russian Direct Investment Fund (RDIF) said the supply of…
The Russian Direct Investment Fund (RDIF) said the supply of the COVID-19 vaccine should enable 25 percent of the population to be vaccinated.
Preliminary data from Phase I/II trails evaluating the vaccine reveal…
Preliminary data from Phase I/II trails evaluating the vaccine reveal 100 percent of participants had a humoral and cellular response, with no serious adverse events reported.
A COVID-19 vaccine dubbed “Sputnik V” has been given regulatory…
A COVID-19 vaccine dubbed “Sputnik V” has been given regulatory approval in Russia, before completing its clinical trials.
The Russian Direct Investment Fund (RDIF) and the ChemRar Group…
The Russian Direct Investment Fund (RDIF) and the ChemRar Group are to deliver the doses of avifavir, approved in Russia as a COVID-19 therapeutic, to Russian hospitals.
